Episode 10

(Published on 05/25/2021)

Indian Innovation Rising to the COVID Challenge

Against the backdrop of India’s punishing second wave of COVID-19, Dr. Raches Ella of Bharat Biotech joins the podcast to talk about the company’s pioneering work in vaccines. He discusses their own COVID-19 vaccine, Covaxin, the challenges India faces right now in administering vaccine to such a large population, and their innovative work in developing a respiratory vaccine to fight a respiratory virus.

Special Guests

Takeaways:

  • 04:07 When the virus hit, Bharat Biotech were well placed to respond. The result is Covaxin.
  • 09:58 Just how effective are the vaccines against the COVID-19 variants of concern?
  • 15:30 20 million doses of Covaxin have been administered in India. While all production is currently mandated for domestic use, the only way out of the pandemic is equitable distribution of vaccine globally.
  • 18:36 India leveraged its childhood vaccination program to roll out the COVID-19 vaccine.
  • 20:15 As a country with high levels of infectious diseases, vaccine hesitancy is not really an issue in India.
  • 22:53 Respiratory vaccine for a respiratory virus: Bharat Biotech have partnered with Washington University in St. Louis to develop an intranasal vaccine. Currently in trials and hoping for release by the end of this year.
  • 26:12 What can the world do right now to help India? A great start would be standardized protocols for treating and managing COVID-19 from the WHO.
  • 31:10 Beyond COVID-19: Bharat Biotech are also working on vaccines for polio, cholera and chikungunya.
Print Friendly, PDF & Email
999 Peachtree St NE,
Atlanta, GA 30309
1-866-747-7667
Facebook-f Twitter Linkedin-in

OFFICE OF HEALTH EQUITY

AND CRISIS COORDINATION

GHC3 is now the Office of Health Equity and Crisis Coordination, a division of the Center for Global Health Innovation (CGHI). The Center for Global Health Innovation is an Atlanta-based 501(c)3 organization launched in 2019 to bring together diverse Global Health, Health Technology and Life Sciences entities to collaborate, innovate and activate solutions to enhance human health outcomes around the world. At its core, CGHI will orchestrate programs that promote cross discipline cooperation to strengthen capabilities, accelerate problem solving and respond to global health crises. The Center will continue to support its subsidiary organizations, Georgia Bio and Georgia Global Health Alliance and is standing up a permanent Global Health Crisis Coordination Center to bringing to bear the best private sector and public sector capabilities and experience in times of need.

Copyright 2023 © Global Health Crisis Coordination Center. All Rights Reserved.
X